Specifically, it was applied to late-onset Alzheimer's disease (AD) patients that paradoxically carried the AD-protective APOE ɛ2 allele compared to healthy individuals that carried the AD-risk APOE ɛ4 allele. Here, APOE is linked to Alzheimer disease.